SeraCare NGS QC software integrated into Philips’ genomics platform
May 18, 2018 - SeraCare Life Sciences has partnered with Navican, an Intermountain Healthcare company, and Royal Philips on the integration of SeraCare’s clinical NGS QC solution to support the rollout of Navican’s TheraMap Precision Cancer Care services. The integrated solution connects SeraCare’s iQ NGS QC Management software to the Philips IntelliSpace Genomics Platform to automate tracking of all genomics workflow QC parameters necessary for monitoring, trending, and reporting on the performance of the TheraMap clinical NGS assay.
SeraCare’s iQ NGS QC Management solution leverages a broad selection of quantitative multiplexed DNA and RNA reference materials with a QC tracking and reporting software solution.